Showing results (61-70 of 486) with videos related to

Sort By:
Pageof 49
Cancer Treatment Reviews|January 4, 2024
Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomesAlmuth Maria Anni Merz, Marie Sébert, Jan Sonntag, et al.
Haematologica|August 20, 2016
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitorsUlrike Baschant, Martina Rauner, Ekaterina Balaian, et al.
Transplantation|September 25, 2008
Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximabMalte von Bonin, Uta Oelschlägel, Jörgen Radke, et al.
Leukemia Research|August 18, 2015
Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDSChristina Ganster, Katayoon Shirneshan, Gabriela Salinas-Riester, et al.
Leukemia Research|April 30, 2018
Associations of myeloid hematological diseases of the elderly with osteoporosis: A longitudinal analysis of routine health care dataThomas Datzmann, Freya Trautmann, Falko Tesch, et al.
Frontiers in Psychology|November 29, 2023
Compliance with medical regimen among hematological cancer patients and its association with symptoms of posttraumatic stress disorder and adjustment disorderFranziska Springer, Peter Esser, Michael Friedrich, et al.
Hemasphere|February 22, 2021
Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell TransplantationDominic Brauer, Donata Backhaus, Rosmarie Pointner, et al.
Frontiers in Oncology|July 10, 2023
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative studyPhilipp Lückemeier, Aleksandar Radujkovic, Udo Holtick, et al.
Blood Advances|August 19, 2020
Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantationJuliane Grimm, Madlen Jentzsch, Marius Bill, et al.
Transplantation and Cellular Therapy|May 10, 2021
Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell TransplantAlessandro Isidori, Federica Loscocco, Giuseppe Visani, et al.
Pageof 49